About Active Motif
We Help Researchers Do Research.
At Active Motif, we believe that knowledge of the epigenome will be key in the development of precision medicine. For that reason, we are committed to developing the best tools and techniques to help researchers elucidate how epigenetic mechanisms impact the genome, transcriptome, and proteome through gene regulation.
A Global Company Built by Scientists, for Scientists.
At Active Motif, we take pride in our experience and depth of knowledge in epigenetics research. With more than 20 years of experience, Active Motif is the industry leader in developing and delivering innovative tools to enable epigenetics and gene regulation research for the life science, clinical and pharmaceutical, and drug discovery communities. The company has a world-leading portfolio of assays, genome-wide services, and validated antibodies for use in epigenetic and gene regulation research and our products and services have been cited in over 1000 publications
Active Motif operates globally through its corporate headquarters in Carlsbad, California, regional headquarters in Belgium, Japan, and China, as well as a worldwide network of sales and support offices. Active Motif applies a multi-disciplinary approach to create new and modifies existing technologies to meet the current and future needs of life science researchers.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of Active Motif
Here you will find Active Motif Inc.
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous